Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Standard BioTools (LAB)
NASDAQ:LAB
Standard BioTools (LAB) Ownership Overview
38.61% Insiders
8.50% Mutual Funds
0.15% Other Institutional Investors
9.98% ETFs
42.76% Public Companies and Individual Investors
The ownership structure of Standard BioTools (LAB) stock is a mix of institutional, retail, and individual investors. Approximately 18.63% of the company’s stock is owned by Institutional Investors, 38.61% is owned by Insiders, and 42.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 29, 2024 | Casdin Partners Master Fund, L.p. Director, >10% Owner | xxxxxxxxxxxxx | $545000 |
| Aug 26, 2024 | Casdin Partners Master Fund, L.p. Director, >10% Owner | xxxxxxxxxxxxx | $1540657 |
| Aug 21, 2024 | Casdin Partners Master Fund, L.p. Director, >10% Owner | xxxxxxxxxxxxx | $2347500 |
| Aug 16, 2024 | Casdin Partners Master Fund, L.p. Director, >10% Owner | xxxxxxxxxxxxx | $1908000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $1123454 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2547130 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $5816455 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 74,036,109 | Insider | 19.89% | 104,390,914 | |
| 66,730,879 | Insider | 17.93% | 94,090,539 | |
| 58,651,170 | Institution | 15.76% | 82,698,150 | |
| 16,328,754 | Institution | 4.39% | 23,023,543 | |
| 14,198,555 | Institution | 3.81% | 20,019,963 | |
| 14,043,446 | Institution | 3.77% | 19,801,259 | |
| 3,588,821 | Institution | 0.96% | 5,060,238 | |
| 3,323,689 | Institution | 0.89% | 4,686,401 | |
| 3,304,719 | Institution | 0.89% | 4,659,654 | |
| 3,266,317 | Institution | 0.88% | 4,605,507 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,043,446 | Institution | 3.77% | 19,801,259 | |
| 3,588,821 | Institution | 0.96% | 5,060,238 | |
| 3,304,719 | Institution | 0.89% | 4,659,654 | |
| 2,967,717 | Institution | 0.80% | 4,184,481 | |
| 1,622,126 | Institution | 0.44% | 2,287,198 | |
| 1,163,979 | Institution | 0.31% | 1,641,210 | |
| 839,974 | Institution | 0.23% | 1,184,363 | |
| 731,389 | Institution | 0.20% | 1,031,258 | |
| 700,000 | Institution | 0.19% | 987,000 | |
| 641,882 | Institution | 0.17% | 905,054 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,171,532 | Institution | 2.46% | 16,050,181 | |
| 7,885,398 | Institution | 2.12% | 11,118,411 | |
| 4,784,970 | Institution | 1.29% | 8,373,698 | |
| 3,246,573 | Institution | 0.87% | 4,317,942 | |
| 2,243,751 | Institution | 0.60% | 3,163,689 | |
| 2,124,716 | Institution | 0.57% | 2,995,850 | |
| 1,434,370 | Institution | 0.39% | 1,907,712 | |
| 1,405,367 | Institution | 0.38% | 2,459,392 | |
| 723,887 | Institution | 0.19% | 1,266,802 | |
| 676,888 | Institution | 0.18% | 954,412 |
FAQ
Who Owns Standard BioTools (LAB)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 38.61% is held by insiders, and 42.76% is held by retail investors.
What percentage of Standard BioTools (LAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of Standard BioTools (LAB) stock is held by institutional investors.
What percentage of Standard BioTools (LAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.76% of Standard BioTools (LAB) stock is held by retail investors.
Who owns the most shares of Standard BioTools (LAB)?
Casdin Partners Master Fund, L.P. owns the most shares of Standard BioTools (LAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.